Anti-PD-1 Antibody Combined With Pegaspargase in the Treatment of Advanced Stage NK/T-cell Lymphoma
Condition: Nasal Type Extranodal NK/T-Cell Lymphoma Interventions: Drug: Pegaspargase; Drug: Anti-PD-1 monoclonal antibody Sponsor: Ruijin Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials